Fundz

Orchard Therapeutics Plc reported raising $34 Million in an initial SEC Form D filing

PRIVATEMar 23, 2023

Amount Raised

$34 Million

$34 Million sold, per SEC Form D (first sale Mar 10, 2023)

Round Type

Venture

LondonBiotechnology

Quick answer

Orchard Therapeutics raised $34 Million in a funding round, dated March 10, 2023. Orchard Therapeutics is based in London, England, United Kingdom.

How much did Orchard Therapeutics raise?
Orchard Therapeutics raised $34 Million in a funding round on March 10, 2023.
What does Orchard Therapeutics do?
Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments..
Where is Orchard Therapeutics based and how big is it?
Orchard Therapeutics is based in London, England, United Kingdom.
Who are the decision-makers at Orchard Therapeutics?
Fundz holds 1 contact at Orchard Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Orchard Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Antiva Biosciences raised $27M on April 24, 2023.
  • Shape Memory Medical raised $4.8M (Seed) on April 24, 2023.
  • Eximis Surgical raised $8.7M (Funding Round) on April 24, 2023.
  • Xsphera BioSciences raised $13M on April 24, 2023.
  • Applied Therapeutics raised $30M on April 23, 2023.
  • Nosh raised $3.5M (Seed) on April 21, 2023.

Who to call at Orchard Therapeutics, and when

A new round usually means Orchard Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Orchard Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Orchard Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Orchard Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Orchard Therapeutics

Location

245 HAMMERSMITH ROAD

London, England, United Kingdom

About

Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Orchard Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts10 people are listed at Orchard Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Orchard Therapeutics's next move

See what Strategic adds

Orchard Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.